Development of a HPLC method for the determination of losartan urinary metabolic ratio to be used for the determination of CYP2C9 hydroxylation phenotypes

Autor:	Dorado P, Machín E, de Andrés F, Me, Naranjo, Em, Peñas-Lledó, Adrián LLerena, Ceiba Fp Ribef, Consortium For The Ibero-American Network Of Pharmacogenomics
Zdroj:	Europe PubMed Central
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1f65750d6b5229ec328a9326bd2c23f1 http://europepmc.org/abstract/med/23093260 Zobrazit plný text záznamu